Beta Integrin Expression Defines Functionally Distinct CD4+ T-Cell Subsets That Are Altered in Ulcerative Colitis

Ngā tūemi rite

• Ulcerative colitis outcomes research in Japan: protocol for an observational prospective cohort study of YOURS (YOu and Ulcerative colitis: Registry and Social network)
  mā: Toshifumi Hibi, me ētahi atu.
  I whakaputaina: (2019-09-01)
• Symptom Improvement of ulceRative colitis after an Induction dose of UStekinumab in Japanese clinical practice (SIRIUS), measured using patient-reported outcomes: a prospective observational study
  mā: Katsuyoshi Matsuoka, me ētahi atu.
  I whakaputaina: (2022-05-01)
• Post-marketing surveillance of tofacitinib in patients with ulcerative colitis in Japan: a analysis of safety and effectiveness in older (≥65 years) and younger (<65 years) patients
  mā: Katsuyoshi Matsuoka, me ētahi atu.
  I whakaputaina: (2026-04-01)
• Machine learning using clinical data at baseline predicts the medium-term efficacy of ustekinumab in patients with ulcerative colitis
  mā: Hiromu Morikubo, me ētahi atu.
  I whakaputaina: (2024-02-01)
• Efficacy and safety of etrasimod in Japanese patients with ulcerative colitis: results from a phase 2 dose-ranging study
  mā: Ken Takeuchi, me ētahi atu.
  I whakaputaina: (2026-04-01)